A Prospective Observational Study of Changes in
Renal Function and Cardiovascular Risk Following
Living Kidney Donation
G.V. Ramesh Prasad,
1,2,3
Deborah Lipszyc,
2
Michael Huang,
2
Michelle M. Nash,
2
and Lindita Rapi
2
The effect of unilateral nephrectomy on the cardiovascular risk profile of living kidney donors has not been prospec-
tively studied. We performed an observational cohort study of 58 living donors to 6 months postdonation for changes
in 24-hr ambulatory blood pressure profiles, renal function, urine protein excretion, body mass index, glucose toler-
ance, and fasting lipid profiles. The 24-hr systolic blood pressure average and night-day ratio were unchanged from
pre- to postdonation (118.911 vs. 118.114 mm Hg, P=0.77; 0.870.07 vs. 0.870.09, P=0.68, respectively).
Estimated glomerular filtration rate declined from 91.916 to 61.612 mL/min/1.73 m
2
(P0.0001). Protein excre-
tion, body mass index, glucose, and lipids were unchanged. No significant differences were noted between dippers and
nondippers either pre- or postdonation. In summary, living kidney donation in the short term is safe. We suggest
further observation of individuals with lower glomerular filtration rate for possible increased cardiovascular risk factors
in the future.
Keywords: Cardiovascular risk, Nephrectomy, Living donors, Ambulatory blood pressure, Renal function, Protein-
uria, Kidney donation.
(Transplantation 2008;86: 1315–1318)
L
iving kidney donors undergo unilateral nephrectomy
without medical benefit. The procedure is considered ac-
ceptably safe (1–9), which is a paradigm based predominantly
on retrospective, cross-sectional studies prone to selection and
information bias (10). Subtle evolution of cardiovascular risk
factors such as blood pressure (BP) elevation and hypertension
(11), decline in kidney function and chronic renal insufficiency
(12), and de novo proteinuria (12) may therefore be undetected.
There is also concern about circadian BP rhythm disturbance,
which may occur with kidney function loss less than required for
hypertension (13), and likewise, there is also concern about de-
velopment of the metabolic syndrome (14).
The purpose of this prospective, observational study
was to describe changes in BP, renal function, and urinary
protein excretion to 6 months postdonation. In addition, we
describe the short-term natural history of additional markers
of cardiovascular risk including the body mass index (BMI),
the fasting lipid profile, and glucose metabolism in a prospec-
tively assembled cohort of living kidney donors.
METHODS
Our hospital performs approximately 100 renal trans-
plants annually, of which one half are derived from living
donors. Presurgical evaluation includes excluding hyperten-
sion by office BP measurement (140/90 mm Hg) and 24-hr
ambulatory BP (ABP) monitoring (135/85 mm Hg); renal
insufficiency: estimated glomerular filtration rate (eGFR)
(70 mL/min/1.73 m
2
); proteinuria (300 mg/24 hr); dia-
betes (fasting blood glucose7.0 mmol/L and/or 2-hr blood
glucose11.1 mmol/L on 75 g oral glucose tolerance testing);
and morbid obesity (BMI40 kg/m
2
). Nephrolithiasis and
surgical contraindications are excluded through abdominal
computerized tomography. Standard postdonation evalua-
tion includes an office visit 3 months postdonation, during
which a sphygmomanometer-measured BP is obtained, renal
function is estimated by the abbreviated Modification of Diet
in Renal Disease (MDRD) equation (15), and a random urine
sample is evaluated for proteinuria. All potential donors re-
ceiving prior approval to donate by an independent team
were approached for participation.
This study was funded by the Dean’s Fund new staff grant program at the
University of Toronto, Canada.
1
Division of Nephrology, University of Toronto, St. Michael’s Hospital,
Toronto, ON, Canada.
2
Renal Transplant Program, St. Michael’s Hospital, Toronto, ON, Canada.
3
Address correspondence to: G.V. Ramesh Prasad, M.B., B.S., M.Sc.,
F.R.C.P.(C), F.A.C.P., Division of Nephrology, University of Toronto, St.
Michael’s Hospital, 61 Queen Street East, 9th Floor, Toronto, ON M5C
2T2, Canada.
E-mail: prasadr@smh.toronto.on.ca
Received 27 June 2008.
Accepted 7 July 2008.
Copyright © 2008 by Lippincott Williams & Wilkins
ISSN 0041-1337/08/8609-1315
DOI: 10.1097/TP.0b013e318188425b
TABLE 1. Demographic characteristics of study
population
Age, yrs (meanSD, 95% CI) 45.311 (42–48)
Gender (M/F) 12/46
Smoker (Y/N) 6/52
Ethnicity
White 38
Black 5
East Asian 8
South Asian 5
Other 2
Relation to recipient
Parent 5
Sibling 9
Child 5
Spouse/partner 27
Friend 12
Transplantation • Volume 86, Number 9, November 15, 2008 1315